Manuscript Structure

For Authors

Article Types, Formatting, Referencing, and Declaration Requirements

The International Journal of Pharma Studies accepts several types of scholarly manuscripts in pharmaceutical sciences and related fields. Authors should select the appropriate article type and follow the manuscript preparation, formatting, referencing, and ethical requirements described below.

1. Article Types

Original Research Article

Presents original experimental, analytical, theoretical, observational, clinical, or applied pharmaceutical research with clear findings and a meaningful scientific contribution. Topics may include drug formulation, drug delivery, pharmacology, pharmaceutical chemistry, pharmacognosy, pharmaceutical analysis, and drug development.

Recommended length: 4,000–12,000 words

Review Article

Provides a comprehensive and critical review of existing pharmaceutical research on a specific topic, including major scientific developments, research gaps, therapeutic applications, and future directions.

Recommended length: 5,000–15,000 words

Case Study / Case Report

Provides a detailed examination of a relevant pharmaceutical or clinical pharmacy case, medication-related problem, adverse drug reaction, pharmaceutical practice, or other appropriate scientific subject. Clinical case reports must meet applicable ethical, consent, and confidentiality requirements.

Recommended length: 3,000–8,000 words

Short Communication / Research Note

Presents concise and significant pharmaceutical research findings, preliminary experimental results, analytical method developments, formulation observations, or focused scientific contributions.

Recommended length: 2,000–4,000 words

Conceptual / Theoretical Article

Discusses or develops concepts, theories, models, frameworks, or theoretical perspectives relevant to pharmaceutical sciences, drug discovery, pharmaceutical technology, medication safety, or healthcare-related pharmaceutical research.

Recommended length: 3,000–10,000 words

Perspective / Commentary

Provides a scholarly discussion or informed perspective on important pharmaceutical, clinical, regulatory, methodological, or emerging scientific issues, including advances in drug development, pharmacovigilance, pharmaceutical biotechnology, and pharmacy practice.

Recommended length: 1,500–4,000 words

The recommended word counts are flexible guidelines and may vary according to the nature, methodology, scientific content, and requirements of the manuscript.

2. Manuscript Formatting

Manuscripts should normally be submitted as Microsoft Word (.docx) files, unless an alternative format or template is specified by the International Journal of Pharma Studies.

Requirement Recommended format
Page size A4
Margins Approximately 2.54 cm (1 inch)
Main text Times New Roman, 10-point, double-spaced
Article title Times New Roman, 16-point, bold
Author names and affiliations Times New Roman, 12-point
Page numbers Consecutive
Headings Clear and consistent
Tables Editable format where possible
Figures and scientific images Clear and suitable for publication
Chemical structures, graphs, and analytical plots Clearly labelled and legible

Authors should use the official journal manuscript template where provided.

Pharmaceutical and experimental studies should include sufficient methodological information to support scientific evaluation and reproducibility. Where applicable, authors should identify the analytical instruments, reagents, reference standards, experimental conditions, validation procedures, statistical methods, and relevant software used in the study.

3. Author Information

Each manuscript should include the full article title, names of all authors, institutional affiliations and country, ORCID iDs where available, and the corresponding author's email address.

All authors must be entered accurately in the online submission system. The corresponding author is responsible for communication with the journal and should confirm that all authors have reviewed and approved the manuscript.

4. Abstract and Keywords

Most manuscripts should include an abstract of approximately 150–300 words, briefly presenting the research background or problem, objective, methodology, principal findings, and conclusion or scientific significance.

For experimental pharmaceutical research, the abstract should summarize the study design, important experimental or analytical methods, key results, and major conclusions where applicable.

Authors should provide 3–8 relevant keywords that accurately describe the subject of the manuscript and support academic search and discovery. Keywords may include relevant pharmaceutical compounds, drug delivery approaches, therapeutic areas, analytical techniques, or pharmaceutical research methods.

5. Manuscript Structure

The structure should be appropriate to the article type and pharmaceutical research methodology. A typical original research article may follow this sequence:

Title → Author Information → Abstract → Keywords → Introduction → Literature Review / Background → Materials and Methods → Results → Discussion → Conclusion → Declarations → References → Supplementary Materials (where applicable)

For pharmaceutical studies, the Materials and Methods section should provide sufficient information about experimental design, materials, procedures, analytical methods, and statistical analysis to support scientific assessment and reproducibility.

Clinical studies, systematic reviews, laboratory investigations, and other specialized research may require different structures or additional reporting elements. Authors should use a clear and logical organization appropriate to their research.

6. References

The International Journal of Pharma Studies follows the Vancouver reference style, unless otherwise specified for a particular article.

Authors should ensure that:

✓ References are numbered in the order in which they are first cited.
✓ In-text citations correspond correctly with the reference list.
✓ All cited sources are included in the reference list.
✓ Bibliographic information is accurate and complete.
✓ DOI information is included wherever a valid DOI exists.
✓ DOI links, journal names, publication years, volume numbers, page ranges, and other reference details are verified and never invented or guessed.
✓ Relevant primary research, pharmaceutical studies, clinical evidence, and authoritative scientific sources are cited where appropriate.

Accurate references help ensure proper scholarly attribution, scientific traceability, and reliable academic discoverability.

7. Figures, Tables, and Supplementary Materials

Figures and tables should be numbered consecutively and cited in the text, each with a clear and informative title or caption.

Photographs and experimental images should generally be provided at 300 dpi or higher, and line drawings at 600 dpi or higher. Tables should remain editable where possible.

Graphs, chromatograms, spectra, microscopy images, chemical structures, formulation diagrams, and other scientific illustrations should be clear, appropriately labelled, and consistent with the reported findings. Authors must not manipulate or selectively alter scientific images in ways that misrepresent the underlying research.

Authors are responsible for obtaining permission and providing appropriate attribution for any copyrighted third-party material.

Supplementary materials—such as datasets, additional tables or figures, analytical validation results, experimental protocols, questionnaires, code, or other supporting research files—may be submitted where relevant and should be clearly identified and cited.

8. Declarations

Where applicable, manuscripts should include the following statements:

Funding
Conflict of Interest
Data Availability
Ethical Approval
Informed Consent
Clinical Trial Registration
Animal Research Ethics
Author Contributions
Acknowledgments
Third-Party Permissions
Use of AI Tools

For example:

Funding: This research received no external funding.

Conflict of Interest: The authors declare that they have no conflict of interest.

Data Availability: The data supporting the findings of this study are available from the corresponding author upon reasonable request, subject to applicable restrictions.

Statements should be included only when they accurately reflect the circumstances of the research. Authors should not use a sample declaration if it does not apply to their study.

Research involving human participants, clinical trials, patient records, biological samples, animals, or other sensitive information must comply with applicable ethical and regulatory requirements. Relevant ethics approval, informed consent, privacy protections, and trial registration details should be provided where required.

9. Authorship and ORCID

Authorship should reflect a substantial scholarly contribution to the research and manuscript. All listed authors should approve the submitted manuscript and its final version.

Contributors who do not meet the applicable authorship criteria may be acknowledged separately.

Any change to the author list after submission should be supported by a written explanation and confirmation from all affected authors, in accordance with the journal's authorship policy.

Authors are strongly encouraged to provide ORCID iDs to support accurate author identification and scholarly attribution.